XMEX
FRAGUAB
Market cap2.43bUSD
Sep 17, Last price
435.00MXN
1D
-0.46%
1Q
-2.77%
Jan 2017
62.93%
Name
Corporativo Fragua SAB de CV
Chart & performance
P/E
8.89
P/S
0.32
EPS
48.95
Div yield, %
3.29%
Shrs. gr., 5y
—
Rev. gr., 5y
12.50%
Revenues
132.12b
+9.88%
Net income
4.69b
-4.39%
CFO
4.09b
-12.16%
Dividend
Mar 30, 202614.3 MXN/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Corporativo Fragua, S.A.B. de C.V. is a holding company that operates a chain of pharmacy stores in Mexico under the Farmacias Guadalajara brand. The company is engaged in the retail of medicines, perfumes, photography equipment, household goods, food, and other miscellaneous items. It also provides various services including maintenance, surveillance, medical services, and logistics.
Key people
Leticia Rodriguez Becerra
Director of Credit and Payment Collections
Cesar Eduardo Rosas Juarez
Corporate Controller
Brenda Silva Rubio
Director of Legal Division, Secretary, Director
Rodrigo Arroyo Jimenez
Director · since 2015
Patricia Arroyo Navarro
Director of Purchase and Institutional Maintenance, Director
Pedro Javier Garibay Garcia de Quevedo
Director
Rene Toussaint Villasenor
Director
IPO date
Oct 03, 1997
Employees
Domiciled in
MX
Incorporated in
MX
Valuation
Title MXN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||